| Name | 4-chloro-2-oxo-3H-1,3-thiazole-5-carbaldehyde |
|---|---|
| Synonyms |
4-chloro-2-oxo-2,3-dihydro-1,3-thiazole-5-carbaldehyde
4-chloro-2,3-dihydro-2-oxo-5-thiazolecarbaldehyde 4-chloro-2-oxo-2,3-dihydrothiazole-5-carbaldehyde 4-Chloro-2,3-dihydro-2-oxo-5-thiazolecarboxaldehyde |
| Density | 1.68g/cm3 |
|---|---|
| Molecular Formula | C4H2ClNO2S |
| Molecular Weight | 163.58200 |
| Exact Mass | 162.94900 |
| PSA | 78.17000 |
| LogP | 0.90230 |
| Index of Refraction | 1.637 |
| HS Code | 2934100090 |
|---|
|
~62%
55359-96-1 |
| Literature: ANADYS PHARMACEUTICALS, INC. Patent: WO2005/121162 A1, 2005 ; Location in patent: Page/Page column 91; 92 ; |
| Precursor 2 | |
|---|---|
| DownStream 1 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |